I feel like clinical trial abundance has at least the whiff of a new cause area within global health. I’m curating this post as a way to kickstart the issue a little bit.
I agree with the author that “It deserves an EA-specific post”, i.e. I’d love to see someone make the case for clinical trial abundance as a cause area. It could be compared to economic growth/ progress work (as a more targeted niche) or to the distribution of existing medicines (vaccines for malaria etc...).
I feel like clinical trial abundance has at least the whiff of a new cause area within global health. I’m curating this post as a way to kickstart the issue a little bit.
I agree with the author that “It deserves an EA-specific post”, i.e. I’d love to see someone make the case for clinical trial abundance as a cause area. It could be compared to economic growth/ progress work (as a more targeted niche) or to the distribution of existing medicines (vaccines for malaria etc...).
Thanks for writing this @Siebe!